{"title":"The Dyadic Association Between Patient Overdose Risk and Family Attitudes Toward Medications for Opioid Use Disorder.","authors":"Kevan Shah, Katherine Nameth, Jasmin Choi, Lane Burgette, Karen Chan Osilla","doi":"10.1097/ADM.0000000000001464","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Strong social support is beneficial in the care of patients with opioid use disorder. While medications for opioid use disorder (MOUD) are the gold standard treatment for OUD, the beliefs of support persons (SP; family, friend, partner of the individual) about MOUD can influence whether a person initiates and adheres to MOUD.</p><p><strong>Methods: </strong>We examined dyadic baseline data (n=219) of patients receiving buprenorphine treatment and their identified SP across five community health clinics in California. We evaluated SP attitudes about and familiarity with MOUD using 5 items and patient risk via sum scores on an opioid overdose risk assessment scale. We conducted multiple linear regression models using opioid overdose risk score as the outcome and SP attitudes as predictors, controlling for SP age, sex, and race as covariates.</p><p><strong>Results: </strong>The majority of SPs (80%) reported being at least somewhat familiar with MOUD, which was associated with patients who had lower opioid overdose risk scores. SPs who reported agreement with the belief statement that people should be able to stop their opioid use on their own without medication were associated with patients with higher opioid overdose risk scores (P=0.048). When adjusting for covariates, only increased familiarity with MOUD and lower patient overdose risk remained significant (P=0.028).</p><p><strong>Conclusions: </strong>Efforts that aim to promote familiarity with and decrease stigmatizing attitudes toward MOUD may be beneficial in both building support in the patient-SP relationship and potentially reducing overdose risk among patients with OUD.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001464","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Strong social support is beneficial in the care of patients with opioid use disorder. While medications for opioid use disorder (MOUD) are the gold standard treatment for OUD, the beliefs of support persons (SP; family, friend, partner of the individual) about MOUD can influence whether a person initiates and adheres to MOUD.
Methods: We examined dyadic baseline data (n=219) of patients receiving buprenorphine treatment and their identified SP across five community health clinics in California. We evaluated SP attitudes about and familiarity with MOUD using 5 items and patient risk via sum scores on an opioid overdose risk assessment scale. We conducted multiple linear regression models using opioid overdose risk score as the outcome and SP attitudes as predictors, controlling for SP age, sex, and race as covariates.
Results: The majority of SPs (80%) reported being at least somewhat familiar with MOUD, which was associated with patients who had lower opioid overdose risk scores. SPs who reported agreement with the belief statement that people should be able to stop their opioid use on their own without medication were associated with patients with higher opioid overdose risk scores (P=0.048). When adjusting for covariates, only increased familiarity with MOUD and lower patient overdose risk remained significant (P=0.028).
Conclusions: Efforts that aim to promote familiarity with and decrease stigmatizing attitudes toward MOUD may be beneficial in both building support in the patient-SP relationship and potentially reducing overdose risk among patients with OUD.
期刊介绍:
The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty.
Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including:
•addiction and substance use in pregnancy
•adolescent addiction and at-risk use
•the drug-exposed neonate
•pharmacology
•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances
•diagnosis
•neuroimaging techniques
•treatment of special populations
•treatment, early intervention and prevention of alcohol and drug use disorders
•methodological issues in addiction research
•pain and addiction, prescription drug use disorder
•co-occurring addiction, medical and psychiatric disorders
•pathological gambling disorder, sexual and other behavioral addictions
•pathophysiology of addiction
•behavioral and pharmacological treatments
•issues in graduate medical education
•recovery
•health services delivery
•ethical, legal and liability issues in addiction medicine practice
•drug testing
•self- and mutual-help.